GO
Loading...

Latest Video

Cramer: Stay long Merck     Tue, 29 Jul '14 | 9:06 AM ET

The "Squawk on the Street" news team discusses the quarterly results of Merck and Pfizer.

Windstream to spin assets into REIT     Tue, 29 Jul '14 | 9:00 AM ET

CNBC's David Faber and Jim Cramer discuss Windstream's spin-off of assets into a publicly traded REIT.

Martin Mucci, Paychex CEO, discusses the latest employment trends and provides a read on job growth.

Cramer: Windstream interesting     Tue, 29 Jul '14 | 8:49 AM ET

CNBC's Jim Cramer shares his thoughts on earnings and where he sees investment opportunities.

Aecom buys Hunt Construction Group     Tue, 29 Jul '14 | 8:42 AM ET

Michael Burke, Aecom Technology CEO, discusses the acquisition of Hunt Construction and the business of infrastructure.

Split decision on Fed policy: Survey     Tue, 29 Jul '14 | 8:32 AM ET

CNBC's Steve Liesman reveals finding from CNBC's exclusive survey on the outcome of Federal Reserve policy.

Twitter, down but not out     Tue, 29 Jul '14 | 8:22 AM ET

Youssef Squali, Cantor Fitzgerald, shares his outlook on Twitter and explains why he think the social media company can still make a comeback.

Where to take interest rate risk     Tue, 29 Jul '14 | 8:16 AM ET

Jeffrey Rosenberg, BlackRock's chief investment strategist, shares his thoughts on how to increase returns amid a low-rate environment.

Big pharma tax attack     Tue, 29 Jul '14 | 8:04 AM ET

Fundamentally, U.S.-based companies are at a disadvantage because of our tax code, says Barbara Ryan, FTI Consulting, sharing her thoughts on tax inversion among the big pharma space.

Big pharma by the numbers     Tue, 29 Jul '14 | 8:02 AM ET

What we are seeing is innovation is not dead, says Barbara Ryan, FTI Consulting, discussing Pfizer and Merck's second quarter results and big Pharma drug trends.

Hilton Hotels goes high-tech     Tue, 29 Jul '14 | 7:44 AM ET

Christopher Nassetta, Hilton Worldwide president & CEO, says Hilton Hotels are revolutionizing the hotel experience by offering guests the ability to check-in, select rooms and customize the hospitality experience all from their smartphones.

Living in a bank settlement world     Tue, 29 Jul '14 | 7:31 AM ET

There's been a tremendous increase in the states getting involved in areas of regulations they did not usually get involved in before, says Eric Dinallo, Debevosie & Plimpton LLP partner, discussing banking regulations.

UBS CFO on litigation     Tue, 29 Jul '14 | 7:21 AM ET
Tom Naratil, CFO of UBS AG

Tom Naratil, UBS CFO, discusses UBS's settlement with Germany on tax evasion charges.

UBS CFO on wealth management     Tue, 29 Jul '14 | 7:18 AM ET

Tom Naratil, UBS CFO, discusses robust growth in UBS's wealth management division.

Jeffrey Rosenberg, BlackRock, shares his thoughts on Fed policy ahead of the FOMC meeting. We no longer need negative two percent interest rates and a massive size balance sheet, says Rosenberg.

Ahead of the Fed: Survey     Tue, 29 Jul '14 | 7:02 AM ET

CNBC's Steve Liesman provides the results of CNBC's survey on what to expect from the Fed before this week's FOMC meeting.

Markets 'fairly valued': Pro     Tue, 29 Jul '14 | 6:38 AM ET

Savita Subramanian, Bank of America Merrill Lynch, and Ed Keon, Quantitative Management Associates, provide insights and investment strategies on the markets.

Secret buyer of Kurdish crude revealed     Tue, 29 Jul '14 | 6:34 AM ET
The United Kalavryta.

CNBC's Michelle Caruso-Cabrera reports Talmay Trading hired a Houston-based company to bring Kurdish oil ashore.

China investigates Microsoft     Tue, 29 Jul '14 | 6:32 AM ET

China is investigating Microsoft for suspected monopoly, reports CNBC's Eunice Yoon.

Manufacturing jobs at risk: Report     Tue, 29 Jul '14 | 6:21 AM ET

Jay Timmons, National Association of Manufacturers CEO, discusses the results of a new report that indicates killing the Export-Import Bank will put thousands of high-paying manufacturing jobs at risk.

Israeli tank shells took out Gaza's largest power source, reports NBC's Martin Fletcher, with the latest detail on the growing crisis.

CNBC's Julia Chatterly reports on all the market moving events from Europe, as Deutsche Bank and UBS report quarterly numbers.

Ranjith Gopinathan, programme manager, life sciences and healthcare practice at Frost & Sullivan, discusses pharmaceutical groups Merck and Pfizer ahead of their quarterly results.

Hessam Nadji, CSO at Marcus and Millichap, discusses the U.S. real estate market and says that on the residential side, the back half of the year should be "pretty strong".

Nothing compares to US equities?     Tue, 29 Jul '14 | 5:00 AM ET

Dan Greenhaus, chief global strategist at BTIG, says that on a relative basis, the U.S. equity market remains "where you want to be".

Why cross-border IPOs are booming     Tue, 29 Jul '14 | 4:45 AM ET

Nick O'Donnell, partner for capital markets at Baker & McKenzie, explains that there's been an "explosion" in cross-border IPOs in the past year.

Is the game over for Nintendo?     Tue, 29 Jul '14 | 4:40 AM ET

Atul Goyal, analyst at Jefferies, says Nintendo needs to change strategy and go where their customers are: mobile.

Deutsche increases litigation reserves     Tue, 29 Jul '14 | 4:30 AM ET

Filippo Alloatti, senior research analyst at Hermes Fund Managers, comments on Deutsche Bank's latest results and says the tone used by management is concerning.

Jean-Dominique Sénard, CEO of Michelin, comments on the group's Russian operations and says Europe needs to be more competitive to deal with moves in the euro currency.

Paul Sedgwick, head of investment at Frank Investments, says that there appears to be a "wall of worry" in most asset classes at the moment, and explains why this earnings season is quite important.

Contact Latest Video

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Video and TV

  • Jeffrey Rosenberg, BlackRock's chief investment strategist, shares his thoughts on how to increase returns amid a low-rate environment.

  • The Apple logo is displayed at the Upper West Side Apple store in New York.

    CNBC's Josh Lipton and USA Today San Francisco Bureau Chief Jon Swartz discuss what Apple's acquisition plans say about its hardware business.

  • What we are seeing is innovation is not dead, says Barbara Ryan, FTI Consulting, discussing Pfizer and Merck's second quarter results and big Pharma drug trends.

U.S. Video

Asia Video

Europe Video